0872-0754 0872-0754 S0872-07542022000100031 10.25753/birthgrowthmj.v31.i1.20898 Portugal Portugal 30 03 2022 30 03 2022 31 1 31 37

1 2018 129 2 2 335-42 2 2019 321 2 2 188-99 3 Bradford PA ?-lactams and ß-lactamase inhibitors: An overview 2016 6 8 8 a025247 4 2019 393 10167 10167 183-98 5 2008 121 7 7 572-6 6 2003 33 4 4 501-6 7 2018 6 1 1 82-9 8 1968 575-96 9 2003 58 10 10 961-72 10 2016 24 2 2 63-78 11 2017 5 3 3 616-25 12 2017 1st 225-46 13 2021 14 31 31 31-46 14 2004 88 179-15 15 1968 33 5 5 428-38 16 2007 57 3 3 S13-8 17 2016 16 3 3 1-12 18 2014 112 5 5 404-12 19 2013 13 1 1 64-70 20 2006 82 5 Suppl 5 Suppl S181 21 2009 64 2 2 183-93 22 2014 20 5 5 428-36 23 2007 136 3 3 340-7 24 2018 6 1 1 72-81 25 2009 64 2 2 183-93 26 2009 39 1 1 43-61 27 2005 115 4 4 1048-57 28 2010 127 1 1 218-22 29 2008 19 1 1 82-5 30 2008 19 7 7 634-8 31 2008 38 1 1 191-8 32 2007 60 5 5 1172-3 33 2012 42 5 5 612-20 34 2009 64 2 2 183-93 35 1996 98 3 3 671-7 36 1966 96 4 4 719 37 2005 16 4 4 341-7 38 2019 7 8 8 2722-38 39 2018 26 4 4 263-71 40 2014 6 6 6 485-95 41 Infarmed 2010 14 1 1 4 42 2015 45 2 2 300-27 43 2021 32 7 7 1426-36 44 Joint Task Force on Practice Parameter.American Academy of Allergy Asthma and Immunology and American College of Allergy Asthma and Immunology 2010 105 259-73 45 2011 8 3 3 43-53